Featured Insights and Perspectives from Darwin
The latest insights, ideas, and perspectives from Darwin, updated bianually. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
October 6, 2025
Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 billion
Learn More
October 6, 2025
acquisition
%20Large.jpeg)
September 29, 2025
acquisition
business
health systems
September 15, 2025
Our Take: Feature: CBO report analyzes 565% increase in 340B drug spending over 11 years
Learn More
September 15, 2025
drug
health systems
September 8, 2025
Our Take: Evernorth invests $3.5 billion in Shields Health, HonorHealth acquires Evernorth Care clinics
Learn More
September 8, 2025
healthcare
merger
acquisition
August 25, 2025
Our Take: Epic shines a spotlight on generative AI projects at annual Users Group Meeting
Learn More
August 25, 2025
artificial intelligence
epic
healthcare podcast
December 5, 2020
Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada
Learn More
December 5, 2020
canada
drug
drugs
fda
.jpg)
October 12, 2020
Our Take: Walmart introduces its health insurance agency, launches co-branded MA plans with Clover Health
Learn More
October 12, 2020
insurers
Defense Health Agency
health plan
health
October 19, 2021
Our Take: Increasingly concentrated health insurance markets may be harming consumers, providers, AMA study suggests
Learn More
October 19, 2021
hospital market concentrations
insurers
health
healthcare
October 26, 2020
health system
health systems
editorial
health
November 2, 2020
health
care
healthcare
merger
November 9, 2020
Our Take: CMS approves controversial waiver, finalizes rules, penalizes hospitals for readmissions
Learn More
November 9, 2020
CMS
hospital
case
health
November 16, 2020
Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA
Learn More
November 16, 2020
vaccine
covid vaccine
covid-19
covid
Stay Aware. Stay Informed.
Want to strengthen your account planning?
Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
